YOU ARE HERE: LAT HomeCollectionsU S Surgical Corp

U S Surgical Corp

January 26, 2006 | From Associated Press
The Federal Circuit court of appeals in Washington upheld a $64.5-million judgment for patent infringement against Tyco International Ltd.'s U.S. Surgical Corp. unit. A law firm representing Applied Medical Resources Corp. of Rancho Santa Margarita said that the court affirmed a $43.5-million damages award, and said the $64.5 million included increased damages and attorney fees.
March 27, 1997 | Dow Jones
Imagyn Medical Inc. said Wednesday it has received clearance from the Food and Drug Administration to market its MicroLap Gold microlaparoscope for the diagnosis and treatment of pelvic pain, infertility and tubal ligation. Imagyn said it will begin shipments of MicroLap Gold to U.S. Surgical Corp. in the second quarter. Imagyn has an agreement for U.S. Surgical to distribute the MicroLap products.
November 30, 1988 | Associated Press
An animal rights activist accused of planting a bomb at a surgical instruments company that experiments on dogs pleaded not guilty Tuesday to charges of attempted murder, possession of explosives and manufacturing a bomb. Fran Stephanie Trutt, 33, of New York City did not speak during her brief appearance in Stamford Superior Court except to say: "Definitely not guilty."
November 11, 1998 | Bloomberg News
Circon Corp. agreed to ease anti-takeover provisions and consider being acquired, bowing to shareholders upset by the surgical-products maker's rejection of a bid from U.S. Surgical Corp. Santa Barbara-based Circon said it will consider new proposals and invited discussions from companies it negotiated with earlier. Norwalk, Conn.-based U.S. Surgical withdrew its $230-million offer Sept. 15 after agreeing to be bought by Tyco International Ltd.
September 17, 1998 | Bloomberg News
Shares of Circon Corp., a maker of minimally invasive surgery products, plunged 29% after U.S. Surgical Corp. said it dropped its $230-million tender offer to buy the company. Shares in the Santa Barbara-based company fell $3.38 to close at $9.88 on Nasdaq. Earlier, the shares touched $9.13, the lowest level for the company in two years. Circon, which has annual sales of about $160 million, has been the target of a hostile takeover bid by U.S. Surgical since 1996. Norwalk, Conn.-based U.S.
April 2, 1999 | Bloomberg News
Tyco International Ltd. and Johnson & Johnson agreed to settle a 10-year-old patent dispute between the companies' medical device subsidiaries. The settlement enables Tyco's U.S. Surgical Corp. and Johnson & Johnson's Ethicon Endo-Surgery Inc. to compete in the surgical instrument market without fighting more patent battles.
November 26, 1997 | (Bloomberg News)
A federal judge has transferred Imagyn Medical Technologies' patent infringement lawsuit against U.S. Surgical Corp. from Virginia to U.S. Surgical's home state of Connecticut. U.S. District Judge James C. Cacheris in Alexandria, Va., ruled that trying the case in a state where neither party has significant operations "would be a great inconvenience to everyone involved," U.S. Surgical said. U.S. Surgical is based in Norwalk, Conn.
October 21, 1998 | Bloomberg News
Circon Corp., a maker of minimally invasive surgery products, said its top executive quit and the company will stop looking for a buyer. The company said Chief Executive and Chairman Richard Auhll resigned, without citing a reason. George Cloutier, a director at Santa Barbara-based Circon, will serve as interim CEO while the company looks for a permanent leader. John Blokker, also a director, is the new chairman of the company, which had 1997 revenue of $160 million.
August 6, 1997 | (Reuters)
U.S. Surgical Corp. said it has begun another hostile tender offer to acquire the rest of Santa Barbara-based Circon Corp., a maker of devices for minimally invasive surgery that it has been pursuing for a year. The offer, which values Circon at about $218 million, is for $16.50 a share. Norwalk, Conn.-based U.S. Surgical also makes products meant to lower the cost of surgery and other medical treatments. It already owns 14.8% of Circon. U.S.
Los Angeles Times Articles